Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway–mediated diseases

Autor: Fridkis-Hareli, Masha *, Storek, Michael, Mazsaroff, Istvan, Risitano, Antonio M., Lundberg, Ante S., Horvath, Christopher J., Holers, V. Michael
Zdroj: In Blood 27 October 2011 118(17):4705-4713
Databáze: ScienceDirect